Author

S. Tabrizifard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Cheng· 1 shared A. Saigal· 1 shared D. Liu· 1 shared E. Carballo-Jane· 1 shared H. H. Shaheen· 1 shared H.-W. Meng· 1 shared J. C. Marquis· 1 shared J. Hicks· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. C. Cheng

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery of A New Class of Integrin Antibodies for Fibrosis

J. Zhang, T. Wang, A. Saigal, J. Johnson, J. Morrisson, S. Tabrizifard, S. A. Hollingsworth, M. J. Eddins, W. Mao, K. O'Neill, M. Garcia-Calvo, E. Carballo-Jane, D. Liu, T. Ham, Q. Zhou, , M. Handa

The paper identifies new integrin antibodies that inhibit fibrosis progression in lung injury models and show superior in vitro activity in fibroblasts.

bioRxiv · Jul 20, 2020Pharmacology & Toxicology